Cilostazol reduces cerebrovascular risk through the inhibition of multi-drug resistance protein 4/ATP Binding Cassette Subfamily C Member 4.

Dear Editor,We read the work by Di Napoli et al. [1] with great interest. We congratulate the authors. In our opinion, cilostazol has the potential to be very important in reducing cerebrovascular ...